Fuqua SA - Search Results

1

Tumour and cellular distribution of activated forms of PR in breast cancers: a novel immunohistochemical analysis of a large clinical cohort.

Bonneterre J, Bosq J, Jamme P, Valent A, Gilles EM, Zukiwski AA, Fuqua SA, Lange CA, O'Shaughnessy J. Bonneterre J, et al. Among authors: fuqua sa. ESMO Open. 2016 Aug 22;1(4):e000072. doi: 10.1136/esmoopen-2016-000072. eCollection 2016. ESMO Open. 2016. PMID: 27843626 Free PMC article.

2

Phosphorylated and sumoylation-deficient progesterone receptors drive proliferative gene signatures during breast cancer progression.

Knutson TP, Daniel AR, Fan D, Silverstein KA, Covington KR, Fuqua SA, Lange CA. Knutson TP, et al. Among authors: fuqua sa. Breast Cancer Res. 2012 Jun 14;14(3):R95. doi: 10.1186/bcr3211. Breast Cancer Res. 2012. PMID: 22697792 Free PMC article.

3

Breast cancer patients with progesterone receptor PR-A-rich tumors have poorer disease-free survival rates.

Hopp TA, Weiss HL, Hilsenbeck SG, Cui Y, Allred DC, Horwitz KB, Fuqua SA. Hopp TA, et al. Among authors: fuqua sa. Clin Cancer Res. 2004 Apr 15;10(8):2751-60. doi: 10.1158/1078-0432.ccr-03-0141. Clin Cancer Res. 2004. PMID: 15102680

4

Abnormal estrogen receptor in clinical breast cancer.

McGuire WL, Chamness GC, Fuqua SA. McGuire WL, et al. Among authors: fuqua sa. J Steroid Biochem Mol Biol. 1992 Sep;43(1-3):243-7. doi: 10.1016/0960-0760(92)90214-4. J Steroid Biochem Mol Biol. 1992. PMID: 1525064 Review.

5

Estrogen receptor beta protein in human breast cancer: correlation with clinical tumor parameters.

Fuqua SA, Schiff R, Parra I, Moore JT, Mohsin SK, Osborne CK, Clark GM, Allred DC. Fuqua SA, et al. Cancer Res. 2003 May 15;63(10):2434-9. Cancer Res. 2003. PMID: 12750263 Free PMC article.

6

Low levels of estrogen receptor beta protein predict resistance to tamoxifen therapy in breast cancer.

Hopp TA, Weiss HL, Parra IS, Cui Y, Osborne CK, Fuqua SA. Hopp TA, et al. Among authors: fuqua sa. Clin Cancer Res. 2004 Nov 15;10(22):7490-9. doi: 10.1158/1078-0432.CCR-04-1114. Clin Cancer Res. 2004. PMID: 15569979

7

Elevated expression of mitogen-activated protein kinase phosphatase 3 in breast tumors: a mechanism of tamoxifen resistance.

Cui Y, Parra I, Zhang M, Hilsenbeck SG, Tsimelzon A, Furukawa T, Horii A, Zhang ZY, Nicholson RI, Fuqua SA. Cui Y, et al. Among authors: fuqua sa. Cancer Res. 2006 Jun 1;66(11):5950-9. doi: 10.1158/0008-5472.CAN-05-3243. Cancer Res. 2006. PMID: 16740736 Free PMC article.

8

Estrogen receptor variants in clinical breast cancer.

McGuire WL, Chamness GC, Fuqua SA. McGuire WL, et al. Among authors: fuqua sa. Mol Endocrinol. 1991 Nov;5(11):1571-7. doi: 10.1210/mend-5-11-1571. Mol Endocrinol. 1991. PMID: 1779964 Review.

9

Expression of wild-type estrogen receptor beta and variant isoforms in human breast cancer.

Fuqua SA, Schiff R, Parra I, Friedrichs WE, Su JL, McKee DD, Slentz-Kesler K, Moore LB, Willson TM, Moore JT. Fuqua SA, et al. Cancer Res. 1999 Nov 1;59(21):5425-8. Cancer Res. 1999. PMID: 10554010

10

Association between the estrogen receptor alpha A908G mutation and outcomes in invasive breast cancer.

Herynk MH, Parra I, Cui Y, Beyer A, Wu MF, Hilsenbeck SG, Fuqua SA. Herynk MH, et al. Among authors: fuqua sa. Clin Cancer Res. 2007 Jun 1;13(11):3235-43. doi: 10.1158/1078-0432.CCR-06-2608. Clin Cancer Res. 2007. PMID: 17545528 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

190 results

Search Page

Filters